Kestra Advisory Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550K | Sell |
2,131
-363
| -15% | -$93.6K | ﹤0.01% | 1891 |
|
|
2025
Q1 | $558K | Sell |
2,494
-2,445
| -50% | -$547K | ﹤0.01% | 1757 |
|
|
2024
Q4 | $1.13M | Buy |
4,939
+118
| +2% | +$27K | 0.01% | 1340 |
|
|
2024
Q3 | $1.18M | Sell |
4,821
-504
| -9% | -$123K | 0.01% | 1232 |
|
|
2024
Q2 | $901K | Buy |
5,325
+3,437
| +182% | +$582K | 0.01% | 1380 |
|
|
2024
Q1 | $374K | Sell |
1,888
-1,771
| -48% | -$351K | ﹤0.01% | 1852 |
|
|
2023
Q4 | $630K | Buy |
3,659
+1,873
| +105% | +$322K | 0.01% | 1390 |
|
|
2023
Q3 | $264K | Buy |
1,786
+15
| +0.8% | +$2.22K | ﹤0.01% | 1751 |
|
|
2023
Q2 | $387K | Buy |
1,771
+153
| +9% | +$33.4K | ﹤0.01% | 1449 |
|
|
2023
Q1 | $354K | Sell |
1,618
-2,388
| -60% | -$523K | ﹤0.01% | 1468 |
|
|
2022
Q4 | $834K | Buy |
4,006
+1,150
| +40% | +$239K | 0.01% | 1143 |
|
|
2022
Q3 | $624K | Sell |
2,856
-3,152
| -52% | -$689K | 0.01% | 1196 |
|
|
2022
Q2 | $1.26M | Buy |
6,008
+3,631
| +153% | +$761K | 0.01% | 863 |
|
|
2022
Q1 | $576K | Buy |
2,377
+73
| +3% | +$17.7K | 0.01% | 1209 |
|
|
2021
Q4 | $600K | Sell |
2,304
-44
| -2% | -$11.5K | 0.01% | 1220 |
|
|
2021
Q3 | $619K | Sell |
2,348
-8
| -0.3% | -$2.11K | 0.01% | 1274 |
|
|
2021
Q2 | $581K | Buy |
2,356
+31
| +1% | +$7.65K | 0.01% | 1214 |
|
|
2021
Q1 | $451K | Sell |
2,325
-25
| -1% | -$4.85K | 0.01% | 1248 |
|
|
2020
Q4 | $493K | Buy |
2,350
+2,329
| +11,090% | +$489K | 0.01% | 1217 |
|
|
2020
Q3 | $306K | Buy |
+21
| New | +$306K | 0.01% | 1103 |
|